Elutia Corporation (ELUT) Price to Earnings Ratio

Elutia Corp - graphic logo of issuer ELUT

The Elutia Inc. (ELUT) price chart on the GURU.Markets platform with the -1.50 indicator is driven by management's strategy to develop regenerative technologies and operational safety. The stability of the exchange rate is supported by the localization of production in the US and a global medical consensus. The business relies on the production of unique protective envelopes for pacemakers, whose antibiotic properties create an insurmountable barrier for competitors in clinics.

Elutia (ELUT) - P/E Multiple from 02/21/2024 to 11/12/2026

Analytical breakdowns for Elutia Inc.

- price and consensus price forecast:
Stock Price elutia.com|ELUT - Price Target Chart
- market capitalization details:
Market Value Elutia Inc.|ELUT - Real Price to Acquire Entire Company
- book capitalization information:
Accounting Value of a Share Elutia|ELUT - Book Capitalization|Market Capitalization to Book Value elutia.com|ELUT - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Ratio Elutia Inc.|ELUT - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Elutia Corporation|ELUT - Company Total Debt|Debt to Book Capital Elutia Inc.|ELUT - Company Long-Term Debt|Company Short-Term Loans and Borrowings Elutia|Quick Ratio elutia.com
- earnings and valuation multiples indicators:
ELUT - Company Net Income|Future Profit Elutia Inc.|ELUT - P/E Multiple|Projected Price to Earnings Ratio Elutia Inc|ELUT - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Elutia Inc.|ELUT - Operating profit before deduction of amortization|Earnings per share for the last four quarters Elutia|ELUT - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months elutia.com|ELUT - Earnings growth in current year|Expected net earnings per share growth next year Elutia Inc.
General company analysis:elutia.com, ELUT
Product sample of Elutia Inc.

Steady demand for Elutia Inc. (ELUT) cardiovascular implants ensures high macro-resilience, making the P/E ratio history a key tool for assessing the business's fair value. This metric correlates market capitalization with net income, determining the price of each unit of real earnings and allowing investors to promptly recognize the risk of overpaying for the brand or the undervaluation of the asset.

Analysis of competing companies

P/E Multiple intuitive.com|Price to Earnings Ratio Danaher (DHR)|Price to Earnings Ratio BDX (BD)|STERIS Corporation - Price to Earnings Ratio|Company Value to Net Income WST|Baxter International - P/E Multiple|Business Payback Period masimo.com MASI|Stevanato Group (STVN) - Price to Earnings Ratio|Price to Earnings Multiple TFX|Price to Earnings Ratio Merit Medical Systems Inc|Nobel Biocare (NVST) - Business Payback Period|Price to Earnings Ratio ICUI (ICU Medical, Inc.)|Market Price to Net Income Ratio XRAY|Price to Earnings Ratio LeMaitre Vascular LMAT|Company Value to Net Income ATRC|STAA: Price to Earnings Ratio|NAGE - P/E Multiple|ZimVie Inc. (ZIMV) - Price to Earnings Ratio|Price to Earnings Ratio angiodynamics.com|CERS (Cerus) - P/E Multiple|Market Cap to Earnings Alpha Teknova TKNO|Price to Earnings Ratio Monogram Technologies Inc (MGRM)|sharpstechnology.com - Price to Earnings Multiple|InfuSystem Holdings, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio UTMD (utahmed.com)|KRMD - Price to Earnings Ratio|Business Payback Period Nyxoah SA NYXH|MBOT: P/E Multiple|Market Cap to Earnings Pro-Dex Inc. (PDEX)|Price to Earnings Ratio Zentek Ltd.|Price to Earnings Ratio MLSS|Price to Earnings Ratio NXGL (NEXGEL)|P/E Multiple retractable.com (RVP)|Harvard Bioscience - Price to Earnings Ratio|Market Price to Net Income Ratio FEMY (Femasys Corporation)|Meihua Medical - P/E Multiple|Business Payback Period Predictive Oncology POAI|CJMB: P/E Multiple|Atrion Corp. (ATRI) - P/E Multiple|Price to Earnings Ratio NURO